Elevated vaspin and leptin levels are associated with obesity in prepubertal Korean children

Endocrine Journal

Volumn 60, Issue 5, 2013, Pages 609-616

  Ko, Byung Joon ^a   Lee, Myoungsook ^b   Park, Hye Soon ^c   Han, Kyungdo ^d   Cho, Geum Joo ^a,e   Hwang, Taik Gun ^e   Kim, Jung Hwan ^f   Lee, Seung Hwan ^a   Lee, Hye Young ^a   Kim, Seon Mee ^a  

^a Korea University College of Medicine   (South Korea)

^b Sungshin Women's University   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

^d The Catholic University of Korea   (South Korea)

^e Guro Gu Public Health Centre   (South Korea)

^f Eulji General Hospital   (South Korea)

Author keywords

Children; Leptin; Obesity; Vaspin

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; VASPIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HOMEOSTASIS; HUMAN; HUMAN EXPERIMENT; KOREA; MALE; MEDICAL EXAMINATION; MEDICAL SOCIETY; NORMAL HUMAN; OBESITY; PRACTICE GUIDELINE; PREPUBERTY; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

BODY MASS INDEX; CHILD; CROSS-SECTIONAL STUDIES; CYTOKINES; FEMALE; HUMANS; INSULIN RESISTANCE; LEPTIN; LOGISTIC MODELS; MALE; MASS SCREENING; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY; OVERWEIGHT; PRACTICE GUIDELINES AS TOPIC; REPUBLIC OF KOREA; RISK; SERPINS; SEX CHARACTERISTICS; SOCIETIES, MEDICAL; UP-REGULATION;

EID: 84878481653     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ12-0384     Document Type: Article

References (35)

1. Yach D, Stuckler D, Brownell KD (2006) Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 12: 62-66.
2. Gunnell DJ, Frankel SJ, Nanchahal K, Peters TJ, Davey Smith G (1998) Childhood obesity and adult cardiovas cular mortality: a 57-y follow-up study based on the Boyd Orr cohort. Am J Clin Nutr 67: 1111-1118.
3. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, et al. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432.
4. Ahima RS, Flier JS (2000) Leptin. Annu Rev Physiol 62: 413-437.
5. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, et al. (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334: 292-295.
6. Harris RB, Zhou J, Redmann SM, Jr., Smagin GN, Smith SR, et al. (1998) A leptin dose-response study in obese (ob/ob) and lean (+/?) mice. Endocrinology 139: 8-19.
7. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, et al. (2002) Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 110: 1093-1103.
8. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, et al. (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307: 426-430.
9. Jin H, Jiang B, Tang J, Lu W, Wang W, et al. (2008) Serum visfatin concentrations in obese adolescents and its correlation with age and high-density lipoprotein cholesterol. Diabetes Res Clin Pract 79: 412-418.
10. Davutoglu M, Ozkaya M, Guler E, Garipardic M, Gursoy H, et al. (2009) Plasma visfatin concentrations in childhood obesity: relationships with insulin resistance and anthropometric indices. Swiss Med Wkly 139: 22-27.
11. Haider DG, Holzer G, Schaller G, Weghuber D, Widhalm K, et al. (2006) The adipokine visfatin is markedly elevated in obese children. J Pediatr Gastroenterol Nutr 43: 548-549.
12. Kolsgaard ML, Wangensteen T, Brunborg C, Joner G, Holven KB, et al. (2009) Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome. Scand J Clin Lab Invest 69: 858-864.
13. Martos-Moreno GA, Kratzsch J, Korner A, Barrios V, Hawkins F, et al. (2011) Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism. Int J Obes (Lond) 35: 1355-1362.
14. Mu J, Feng B, Ye Z, Yuan F, Zeng W, et al. (2011) Visfatin is related to lipid dysregulation, endothelial dysfunction and atherosclerosis in patients with chronic kidney disease. J Nephrol 24: 177-184.
15. Haider DG, Schindler K, Schaller G, Prager G, Wolzt M, et al. (2006) Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab 91: 1578-1581.
16. Hida K, Wada J, Eguchi J, Zhang H, Baba M, et al. (2005) Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci U S A 102: 10610-10615.
17. Youn BS, Kloting N, Kratzsch J, Lee N, Park JW, et al. (2008) Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 57: 372-377.
18. Choi SH, Kwak SH, Lee Y, Moon MK, Lim S, et al. (2011) Plasma vaspin concentrations are elevated in metabolic syndrome in men and are correlated with coronary atherosclerosis in women. Clin Endocrinol (Oxf) 75: 628-635.
19. Auguet T, Quintero Y, Riesco D, Morancho B, Terra X, et al. (2011) New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med Genet 12: 60.
20. Suleymanoglu S, Tascilar E, Pirgon O, Tapan S, Meral C, et al. (2009) Vaspin and its correlation with insulin sensitivity indices in obese children. Diabetes Res Clin Pract 84: 325-328.
21. Korner A, Neef M, Friebe D, Erbs S, Kratzsch J, et al. (2011) Vaspin is related to gender, puberty and deteriorating insulin sensitivity in children. Int J Obes (Lond) 35: 578-586.
22. Chang HM, Lee HJ, Park HS, Kang JH, Kim KS, et al. (2010) Effects of weight reduction on serum vaspin concentrations in obese subjects: modification by insulin resistance. Obesity (Silver Spring) 18: 2105-2110.
23. Golpaie A, Tajik N, Masoudkabir F, Karbaschian Z, Talebpour M, et al. (2011) Short-term effect of weight loss through restrictive bariatric surgery on serum levels of vaspin in morbidly obese subjects. Eur Cytokine Netw 22: 181-186.
24. Lee MK, Jekal Y, Im JA, Kim E, Lee SH, et al. (2010) Reduced serum vaspin concentrations in obese children following short-term intensive lifestyle modification. Clin Chim Acta 411: 381-385.
25. Koiou E, Tziomalos K, Dinas K, Katsikis I, Kalaitzakis E, et al. (2011) The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome. Endocr J 58: 237-246.
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
27. Committee on Health and Statistics, Korean Pediatrics Society (2007) Korean physical growth standards for children and adolescents. Korean Pediatrics Society, Seoul, Korea (In Korean).
28. Barlow SE (2007) Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 120 Suppl 4: S164-192.
29. Teshigawara S, Wada J, Hida K, Nakatsuka A, Eguchi J, et al. (2012) Serum vaspin concentrations are closely related to insulin resistance, and rs77060950 at SERPINA12 genetically defines distinct group with higher serum levels in Japanese population. J Clin Endocrinol Metab 97: E1202-1207.
30. Breitfeld J, Tonjes A, Bottcher Y, Schleinitz D, Wiele N, et al. (2012) Genetic variation in the vaspin gene affects circulating serum vaspin concentrations. Int J Obes (Lond) 2012 Aug 21. doi: 10.1038/ijo.2012.133. [Epub ahead of print].
31. von Loeffelholz C, Mohlig M, Arafat AM, Isken F, Spranger J, et al. (2010) Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans. Eur J Endocrinol 162: 507-513.
32. Hassink SG, Sheslow DV, de Lancey E, Opentanova I, Considine RV, et al. (1996) Serum leptin in children with obesity: relationship to gender and development. Pediatrics 98: 201-203.
33. Lahlou N, Landais P, De Boissieu D, Bougneres PF (1997) Circulating leptin in normal children and during the dynamic phase of juvenile obesity: relation to body fatness, energy metabolism, caloric intake, and sexual dimorphism. Diabetes 46: 989-993.
34. Araki S, Dobashi K, Kubo K, Kawagoe R, Yamamoto Y, et al. (2008) Plasma visfatin concentration as a surrogate marker for visceral fat accumulation in obese children. Obesity (Silver Spring) 16: 384-388.
35. Tascilar ME, Cekmez F, Meral C, Pirgon O, Tanju IA, et al. (2011) Evaluation of adipocytokines in obese children with insulin resistance. Turk J Pediatr 53: 269-273.